Loading
Loading
We use strictly necessary cookies to run this site, and analytics cookies to understand how it's used. See our Privacy Policy for details.
AI is helping companies interpret biological data for drug discovery and more personalized care.
Summary
Healthcare technology company Flahy Inc. is applying that approach to clinical decision support, bringing together information that could affect a person’s next step in prevention or treatment, according to Jagjit Singh (pictured, right), founder and chief executive officer of Flahy.
This is a brief wire summary, the full story (linked below) has the complete details.
KazaSec's take
AI-related security incidents are a genuinely new category, prompt injection, model manipulation, and data leakage through an LLM integration don't map cleanly onto traditional application security testing, and are worth assessing deliberately rather than assuming existing controls already cover them.
Coverage details
We've archived 752 other articles touching the same topic (thecube + nyse wired, enterprise ai, flahy) , see the full security news archive.
Relevant from KazaSec
More coverage on this topic
We help organizations find and fix the gaps before they make headlines.